Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders, as well as innovative thinkers who are working to meet the challenges of the coronavirus pandemic.

In this installment, I check in with Peter Webner, CEO of Zionexa US, a French-American biotech company producing a PET tracer for breast cancer called Cerianna, which was approved in May and will be launched in early 2020 in partnership with PETNET Solutions.

We discuss how the PET agent works, and how it is poised to improve breast cancer outcomes. Full prescribing information for Cerianna (fluoroestradiol F18) injection is available at https://www.cerianna.com/wp-content/uploads/2020/05/cerianna-prescribing-information.pdf

We hope you enjoy the video. Please tell us what you think, and let us know who you would like to see interviewed next: